BioSpace News Archive

Increasing prevalence of chronic injuries along with rising awareness of bioactive dressings are the factors driving market growth.

High prevalence of cancer, technical knowledge about gene expression and favorable research funding scenario would drive market growth.

Increasing investments in research and development activities, growing demand for bioinformatics in various application sector, and rising demand for data integration of huge data are key factors fueling global market growth.

Aerovate Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, announced the pricing of its upsized initial public offering of 8,682,142 shares of common stock at a public offering price of $14.00 per share, before underwriting discounts and commissions.

Health Canada is updating the product monograph—or label—for the AstraZeneca and COVISHIELD COVID-19/ vaccines to add capillary leak syndrome as a potential side effect, with a warning for patients with a history of capillary leak syndrome to not get the AstraZeneca or COVISHIELD COVID-19 vaccine.